Oral Oncology
Volume 39, Issue 5 , Pages 515-520 , July 2003

Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis

  • Yasusei Kudo

      Affiliations

    • Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • ,
  • Shojiro Kitajjma

      Affiliations

    • Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • ,
  • Sunao Sato

      Affiliations

    • Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • ,
  • Mutsumi Miyauchi

      Affiliations

    • Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • ,
  • Ikuko Ogawa

      Affiliations

    • Clinical Laboratory, Hiroshima University Dental Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • ,
  • Takashi Takata

      Affiliations

    • Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-82-257-5634; fax: +81-82-257-5619

Received 11 December 2002 ,Accepted 27 January 2003.

References 

  1. Regezi JA, Sciubba JJ. Oral pathology: clinical-pathologic correlations. Philadelphia: W.B.Saunders; 1989;
  2. Fidler U. Critical factors in the biology of human cancer metastasis (twenty-eighth GHA Clowes Memorial Award Lecture). Cancer Res. 1990;50(19):6130–6138
  3. Fidler U. Tumor heterogenity and the biology of cancer invasion and metastasis. Cancer Res. 1978;38(9):2651–2660
  4. Fearon ER, Vogelstem B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767
  5. Marx J. Many gene changes found in cancer. Science. 1989;246(4936):1386–1388
  6. Sherr CJ. G1 phase progression (cycling on cue). Cell. 1994;79(4):551–555
  7. Hunter T, Pines J. Cycins and cancer II (cyclin D and CDK inhibitors come of age). Cell. 1994;79(4):573–582
  8. Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672–1677
  9. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994;78(1):67–74
  10. Polyak K, Lee MH, Erdjument-Bromage H, Tempst P, Massague J. Cloning of p27Kip1, a cyclin-Cdk inhibitor and potential mediator of extracellular antimitogenic signals. Cell. 1994;78(1):59–66
  11. Cruz lB, Snijders PJ, Meijer CI, Braakhuis BJ, Snow GB, Walboomers JM, et al.  p53 expression above the basal cell layer in oral mucosa is an early event of malignant tranaformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 1998;184(4):360–368
  12. Kudo Y, Takata T, Ogawa I, Sato S, Nikai H. Expression of p53 and p21CIP1/WAF1 proteins in oral epitheial dysplasias and squamous cell carcinomas. Oncol Rep. 1999;6(3):539–545
  13. Kudo Y, Takata T, Yasu W, Ogawa I, Miyauchi M, Takekoshi T, et al.  Reduced expression of cyclin-dependent kinase p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer. 1998;83(12):2447–2455
  14. Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, et al.  Reduced expression of p27Kip1 correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett. 2000;151(2):217–222
  15. Slingerland JM, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 2000;183(1):10–17
  16. Kudo Y, Takata T, Ogawa I, Kaneda T, Sato S, Takekoshi T, et al.  p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res. 2000;6(3):916–923
  17. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal O, Chau V, et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995;269(5224):682–685
  18. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3(2):231–234
  19. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat Med. 1997;3(2):222–225
  20. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein (prognostic implications in primary breast cancer). Nat Med. 1997;3(2):227–230
  21. Fredersdorf S, Bums J, Milne AM, Packham G, Falhis L, Gilhett CE, et al.  High level expression of p27Kip1 and cyclin Dl in some human breast cancer cells: inverse correlation between the expression of p27Kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sd USA. 1997;94(12):6380–6385
  22. Yasui W, Kudo Y, Semba S, Yokozaki H, Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res. 1997;88(7):625–629
  23. St Croix B, Sheehan C, Rak JW, Florenes VA, Shingerland JM, et al.  E cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27Kip1. J Cell Biol. 1998;142(2):557–571
  24. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cychin-dependent kinase inhibitor p27Kip1. EMBO J. 1997;16(17):5334–5344
  25. Montagnoli A, Flore F, Eytan E, Carrano AC, Draetta GF, Hershko A, et al.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 1999;13(19):1181–1189
  26. Nguyen H, Gitig DM, Koff A. Cell-free degradation of p27Kip1, a G1 cychin-dependent kinase inhibitor, is dependent on CDK2 activity and proteasome. Mol Cell Bioh. 1999;19(2):1190–1201
  27. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1(4):193–199
  28. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, et al.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol. 1999;1(4):207–214
  29. Kudo Y, Kitajima S, Ogawa I, Sato S, Miyauchi M, Takata T. High expression of Skp2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 2001;61(19):7044–7077

PII: S1368-8375(03)00015-0

doi: 10.1016/S1368-8375(03)00015-0

Oral Oncology
Volume 39, Issue 5 , Pages 515-520 , July 2003

Article Tools

* Image Usage & Resolution